Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Allows Outsourcers To Compound Hydroxychloroquine As COVID-19 Drives Demand
Pharmacies Say More Additions Needed
Mar 30 2020
•
By
Joanne S. Eglovitch
FDA Lets Outsourcers Bulk-Compound Malaria Drug That May Help Against COVID-19 • Source: Shutterstock
More from Manufacturing
More from Compliance